Trade Summary

1 week ago, Genmab A/S, serving as 10% owner at Merus N.V. (MRUS), purchased 278,441 shares at $97.00 per share, for a total transaction value of $27,008,777.00. Following this transaction, Genmab A/S now holds 72,013,065 shares of MRUS.

The trade was executed on Thursday, December 18, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 22, 2025, 4 days after the trade was made.

Merus N.V. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.